Department of Dermatology Visiting Professor Lecture

All are welcome.

Lecture Title: "Vitiligo Treatment from the Bronze Age to the Age of Biologics: New Hope for an Ancient Disease"

John Harris, MD, PhD, was recently named the inaugural chair of dermatology at the newly formed Mass General Brigham (MGB), a merger of the existing Mass General Hospital and Brigham and Women's Hospital in the Harvard University system. Harris is a dermatologist and physician-scientist, caring for patients in a vitiligo specialty clinic and running a research laboratory focused on understanding disease pathogenesis and developing new treatments. His group integrates basic, translational, and clinical research strategies to accomplish this. As a result, clinical trials in vitiligo have shown success. Harris founded Villaris Therapeutics (acquired by Incyte in 2022) and four other companies to develop treatments for inflammatory skin diseases, which were merged into Alys Pharmaceuticals. He serves as Chief Scientific Advisor for Alys, which has two clinical-stage programs, as well as multiple preclinical programs in development.